Skip to main content

Advertisement

Log in

Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Lysozyme is an enzymatic marker of acinar and intercalated duct cells of normal salivary glands. The aim of this study was to verify whether lysozyme expression could be useful to distinguish acinic cell carcinoma (ACC) from its main mimic, mammary analog secretory carcinoma (MASC). For comparison, DOG1 expression was analyzed as well. Seventeen cases of ACC, 15 MASC, and 125 other salivary tumors were studied. Lysozyme expression was found in tumor cells as well as in secreted material of MASC (86.6 % of cases) and in ductal cells of epithelial–myoepithelial carcinoma (EMC-53.8 %), pleomorphic adenoma (PA-29.1 %) and polymorphous low-grade adenocarcinoma (PLGA-23.8 %). However, in ACC, lysozyme was not expressed. Three patterns of DOG1 staining were seen: apical–luminal, cytoplasmic, and mixed cytoplasmic/membranous. The apical–luminal pattern was detected in ductal cells of ACC (58.8 % of cases), EMC (38.4 %), adenoid-cystic carcinoma (AdCC-35.3 %), PA (8.3 %), and PLGA (4.8 %). These tumors also showed mixed membranous/cytoplasmic staining for DOG1. MASC, mucoepidermoid, and salivary duct carcinomas exhibited only DOG1 cytoplasmic staining. In conclusion, lysozyme cannot be used as a marker of acinar differentiation in salivary tumors. However, lysozyme expression can be helpful to distinguish MASC from ACC due to its high frequency in the former and absence in ACC. It is likely that in MASC, lysozyme expression may reflect a lactational-like secretory differentiation since lysozyme belongs to breast milk proteins. Regarding DOG1 expression, the apical–luminal pattern is related to acinar and intercalated duct differentiation whereas the cytoplasmic staining does not seem to be associated with a specific cellular phenotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pinto A, Nosé V, Rojas C, Fan YS, Gomez-Fernandez C. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics. Mod Pathol. 2014;27:30–7.

    Article  CAS  PubMed  Google Scholar 

  2. Bishop JA. Unmasking MASC: bringing to light the unique morphologic, immunohistochemical and genetic features of the newly recognized mammary analogue secretory carcinoma of salivary glands. Head Neck Pathol. 2013;7:35–9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Urano M, Nagao T, Miyabe S, Ishibashi K, Higuchi K, Kuroda M. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6–NTRK3 translocation and novel surrogate markers. Hum Pathol. 2015;46:94–103.

    Article  CAS  PubMed  Google Scholar 

  4. Chiosea SI, Griffith C, Assaad A, Seethala RR. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol. 2012;36:343–50.

    Article  PubMed  Google Scholar 

  5. Griffith C, Seethala R, Chiosea SI. Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma. Virchows Arch. 2011;459:117–8.

    Article  PubMed  Google Scholar 

  6. Chiosea SI, Griffith C, Assaad A, Seethala RR. Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands. Histopathology. 2012;61:387–94.

    Article  PubMed  Google Scholar 

  7. Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6–NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608.

    PubMed  Google Scholar 

  8. Connor A, Perez-Ordoñez B, Shago M, Skálová A, Weinreb I. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol. 2012;36:27–34.

    Article  PubMed  Google Scholar 

  9. Jung MJ, Song JS, Kim SY, Nam SY, Roh JL, Choi SH, et al. Finding and characterizing mammary analogue secretory carcinoma of the salivary gland. Korean J Pathol. 2013;47:36–43.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Stenman G. Fusion oncogenes in salivary gland tumors:molecular and clinical consequences. Head Neck Pathol. 2013;7:12–9.

    Article  PubMed Central  Google Scholar 

  11. Skálová A. Mammary analogue secretory carcinoma of salivar gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity. Head Neck. 2013;7(Suppl 1):S30–36.

    Article  Google Scholar 

  12. Bishop JA, Yonescu R, Batista D, Begum S, Eisele DW, Westra WH. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6–NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma. Hum Pathol. 2013;44:1982–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Chênevert J, Duvvuri U, Chiosea S, Dacic S, Cieply K, Kim J, et al. DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol. 2012;25:919–29.

    Article  PubMed  Google Scholar 

  14. Simpson RH, Skálová A, Di Palma S, Leivo I. Recent advances in the diagnostic pathology of salivary carcinomas. Virchows Arch. 2014;465:371–84.

    Article  CAS  PubMed  Google Scholar 

  15. Mariano FV, dos Santos HT, Azañero WD, da Cunha IW, Coutinho-Camilo CM, de Almeida OP, et al. Mammary analogue secretory carcinoma of salivar glands is a lipid-rich tumour, and adipophilin can be valuable in its identification. Histopathology. 2013;63:558–67.

    PubMed  Google Scholar 

  16. Hsieh MS, Chou YH, Yeh SJ, Chang YL. Papillary cystic pattern in characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland. Virchows Arch. 2015;467:145–53.

    Article  CAS  PubMed  Google Scholar 

  17. Caselitz J, Jaup T, Seifert G. Lactoferrin and lysozyme in carcinomas of the parotid gland: a comparative immunocytochemical study with the occurrence in normal and inflammated tissue. Virchows Arch. 1981;394:61–73.

    Article  CAS  Google Scholar 

  18. Korsrud FR, Brandtzaeg P. Characterization of epithelial elements in human major salivary glands by functional markers: localization of amylase, lactoferrin, lysozyme, secretory component and secretory immunoglobulins by paired immunofluorescence staining. J Histochem Cytochem. 1982;30:657–66.

    Article  CAS  PubMed  Google Scholar 

  19. Habata I, Yasui T, Fujimori O, Tsukise A. Immunohistochemical aspects of anti-microbial properties in goat submandibular glands. Anat Histol Embryol. 2012;41:54–9.

    Article  CAS  PubMed  Google Scholar 

  20. Weinreb I, Seethala RR, Hunt JL, Chetty R, Dardick I, Perez-Ordoñez B. Intercalated duct lesions of salivary gland: a morphologic spectrum from hyperplasia to adenoma. Am J Surg Pathol. 2009;33:1322–9.

    Article  PubMed  Google Scholar 

  21. Montalli VA, Martinez E, Tincani A, Martins A, Abreu Mdo C, Neves C, et al. Tubular variant of basal cell adenoma shares immunophenotypical features with normal intercalated ducts and s closely related to intercalated duct lesions of salivary gland. Histopathology. 2014;64:880–9.

    Article  PubMed  Google Scholar 

  22. Chow BD, Reardon JL, Perry EO, Laforce-Nesbitt SS, Tucker R, Bliss JM. Host defense proteins in breast milk and neonatal yeast colonization. J Hum Lact. 2016;32:168–73.

    Article  PubMed  Google Scholar 

  23. Vizoso F, Plaza E, Vázquez J, Serra C, Lamelas ML, González LO, et al. Lysozyme expression by breast carcinomas, correlation with clinicopathologic parameters, and prognostic significance. Ann Surg Oncol. 2001;8:667–74.

    Article  CAS  PubMed  Google Scholar 

  24. Yang YD, Cho H, Koo JY, Tak MH, Cho Y, Shim WS, et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature. 2008;455:1210–5.

    Article  CAS  PubMed  Google Scholar 

  25. Galietta LJ. The TMEM16 protein family: a new class of chloride channels? Biophys J. 2009;16(97):3047–53.

    Article  Google Scholar 

  26. Stevens TM, Kovalovsky AO, Velosa C, Shi Q, Dai Q, Owen RP, et al. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study. Mod Pathol. 2015;28:1084–100.

    Article  CAS  PubMed  Google Scholar 

  27. Hemminger J, Iwenofu OH. Discovered on gastrointestinal stromal tumors 1 (DOG1) expression in non-gastrointestinal stromal tumor (GIST) neoplasms. Histopathology. 2012;61:170–7.

    Article  PubMed  Google Scholar 

  28. Chan JK. Newly available antibodies with practical applications in surgical pathology. Int J Surg Pathol. 2013;21:553–72.

    Article  PubMed  Google Scholar 

  29. Qu Z, Yao W, Yao R, Liu X, Yu K, Hartzell C. The Ca(2+) -activated Cl(−) channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis. Cancer Med. 2014;3:453–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Raboh NM, Hakim SA. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas. In J Clin Exp Pathol. 2015;8:9214–22.

    Google Scholar 

  31. Thompson LD, Aslam MN, Stall JN, Udager AM, Chiosea S, McHugh JB. Clinicopathologic and immunophenotypic characterization of 25 cases of Acinic Cell Carcinoma with high-grade transformation. Head Neck Pathol. 2016;10:152–60.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Albina Altemani.

Additional information

Fernanda Viviane Mariano and Camila Andrea Concha Gómez have contributed equally to this study, and should be considered as first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mariano, F.V., Gómez, C.A.C., de Souza do Nascimento, J. et al. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands. Head and Neck Pathol 10, 429–436 (2016). https://doi.org/10.1007/s12105-016-0718-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-016-0718-5

Keywords

Navigation